Association of apolipoprotein A1 -75 G/A polymorphism with susceptibility to the development of acute lung injury after cardiopulmonary bypass surgery

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Tu, Jie ^a   Zhang, Bingdong ^a   Chen, Yanhua ^a   Liang, Beiwei ^a   Liang, Dongke ^a   Liu, Guofeng ^a   He, Fang ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Apolipoprotein A1; Cardiopulmonary bypass; Gene polymorphism

Indexed keywords

APOLIPOPROTEIN A1;

ACUTE LUNG INJURY; ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OPERATION DURATION; PERIPHERAL VASCULAR DISEASE; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURVIVAL RATE;

ACUTE LUNG INJURY; AGED; ALLELES; APOLIPOPROTEIN A-I; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; SURVIVAL ANALYSIS;

EID: 84887206383     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-172     Document Type: Article

References (30)

1. Identification of patients at greatest risk for developing major complications at cardiac surgery. Hammermeister KE, Burchfiel C, Johnson R, Grover FL, Circulation 1990 82 V380 IV389 2225429
2. Neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury after cardiopulmonary bypass in the rabbit endotoxemia model. Wakayama F, Fukuda I, Suzuki Y, Kondo N, Ann Thorac Surg 2007 83 153 160 10.1016/j.athoracsur. 2006.08.023 17184651 (Pubitemid 44917894)
3. Acute lung injury during cardiopulmonary bypass, the role of neutrophil sequestration and lipid peroxidation. Westaby S, Fleming J, Royston D, Trans Am Soc Artif Intern Organs 1985 31 604 609 3837518
4. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. Bando K, Pillai R, Cameron DE, Brawn JD, Winkelstein JA, Hutchins GM, Reitz BA, Baumgartner WA, J Thorac Cardiovasc Surg 1990 99 873 877 2329826 (Pubitemid 20162953)
5. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM, Ann Thorac Surg 1999 68 1107 1115 10.1016/S0003-4975(99)00781-X 10510030 (Pubitemid 29530528)
6. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, et al. Am J Respir Crit Care Med 2003 167 1027 1035 10.1164/rccm.200208-966WS 12663342 (Pubitemid 36408170)
7. ApolipoproteinA1-75 G/A (M1-) polymorphism and lipoprotein(a); anti- vs. pro-Atherogenic properties. Albahrani AI, Usher JJ, Alkindi M, Marks E, Ranganath L, Al-yahyaee S, Lipids Health Dis 2007 6 19 10.1186/1476-511X-6-19 17683612 (Pubitemid 47509185)
8. Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Saha N, Tay JS, Low PS, Humphries SE, Genet Epidemiol 1994 11 255 264 10.1002/gepi.1370110304 8088506 (Pubitemid 24184734)
9. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, Am J Respir Crit Care Med 1994 149 818 824 10.1164/ajrccm.149.3. 7509706 7509706 (Pubitemid 24082248)
10. Genetic polymorphisms associated with acute lung injury. Reddy AJ, Kleeberger SR, Pharmacogenomics 2009 10 1527 1539 10.2217/pgs.09.89 19761373
11. Association of interleukin 18 gene polymorphism with susceptibility to the development of acute lung injury after cardiopulmonary bypass surgery. Chen S, Xu L, Tang J, Tissue Antigens 2010 76 245 249 10.1111/j.1399-0039.2010.01506. x 20522205
12. Association between inflammatory genetic polymorphism and acute lung injury after cardiac surgery with cardiopulmonary bypass. Wang JF, Bian JJ, Wan XJ, Zhu KM, Sun ZZ, Lu AD, Med Sci Monit 2010 16 R260 CR265 20424554
13. Association of PBEF gene polymorphisms with acute lung injury, sepsis, and pneumonia in a northeastern Chinese population. Liu Y, Shao Y, Yu B, Sun L, Lv F, Clin Chem Lab Med 2012 50 1917 1922 23093105
14. Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome. Bajwa EK, Yu CL, Gong MN, Thompson BT, Christiani DC, Crit Care Med 2007 35 1290 1295 10.1097/01.CCM.0000260243.22758.4F 17414088 (Pubitemid 46642656)
15. The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS. Tsangaris I, Tsantes A, Bonovas S, Lignos M, Kopterides P, Gialeraki A, Rapti E, Orfanos S, Dimopoulou I, Travlou A, Armaganidis A, Thromb Res 2009 123 832 836 10.1016/j.thromres.2008.07.018 18804848
16. Association of human NAD(P)H: quinone oxidoreductase 1 (NQO1) polymorphism with development of acute lung injury. Reddy AJ, Christie JD, Aplenc R, Fuchs B, Lanken PN, Kleeberger SR, J Cell Mol Med 2009 13 1784 1791 10.1111/j.1582-4934.2008.00581.x 19017358
17. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. Marzec JM, Christie JD, Reddy SP, Jedlicka AE, Vuong H, Lanken PN, Aplenc R, Yamamoto T, Yamamoto M, Cho HY, Kleeberger SR, FASEB J 2007 21 2237 2246 10.1096/fj.06-7759com 17384144 (Pubitemid 47026458)
18. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Gao L, Grant A, Halder I, Brower R, Sevransky J, Maloney JP, Moss M, Shanholtz C, Yates CR, Meduri GU, et al. Am J Respir Cell Mol Biol 2006 34 487 495 10.1165/rcmb.2005-0404OC 16399953
19. Comparison of lipid profiles with APOA1 MspI polymorphism in obese children with hyperlipidemia. Toptas B, Gormus U, Ergen A, Gurkan H, Kelesoglu F, Darendeliler F, Bas F, Dalan AB, Izbirak G, Isbir T, In Vivo 2011 25 425 430 21576418
20. Polymorphism in apoA1 influences high-density lipoprotein cholesterol levels but is not a major risk factor of alzheimer's disease. Smach MA, Edziri H, Charfeddine B, Ben Othman L, Lammouchi T, Ltaief A, Nafati S, Dridi H, Bennamou S, Limem K, Dement Geriatr Cogn Dis Extra 2011 1 249 257 10.1159/000329910 22323901
21. Association of polymorphisms in apolipoprotein A1 and apolipoprotein B genes with lipid profile in Tamilian population. Padmaja N, Kumar MR, Adithan C, Indian Heart J 2009 61 51 54 19729689
22. Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD. Souverein OW, Jukema JW, Boekholdt SM, Zwinderman AH, Tanck MW, Eur J Hum Genet 2005 13 445 451 10.1038/sj.ejhg.5201362 15657615 (Pubitemid 40528350)
23. APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals. Sorkin SC, Forestiero FJ, Hirata MH, Guzman EC, Cavalli SA, Bertolami MC, Salazar LA, Hirata RD, Clin Chem Lab Med 2005 43 1339 1345 16309370
24. Apolipoprotein A1-75 G/A and +83 C/T polymorphisms: susceptibility and prognostic implications in breast cancer. Hamrita B, Ben Nasr H, Gabbouj S, Bouaouina N, Chouchane L, Chahed K, Mol Biol Rep 2011 38 1637 1643 10.1007/s11033-010-0274-0 20842444
25. Apolipoprotein A1 gene polymorphism (G-75A and C + 83 T) in patients with myocardial infarction: a pilot study in a north Indian population. Dawar R, Gurtoo A, Singh R, Am J Clin Pathol 2010 134 249 255 10.1309/AJCPKPTXQ3QN1IFG 20660328
26. An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis. Koutsis G, Panas M, Giogkaraki E, Karadima G, Sfagos C, Vassilopoulos D, Mult Scler 2009 15 174 179 18805838
27. Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity. Chen ES, Mazzotti DR, Furuya TK, Cendoroglo MS, Ramos LR, Araujo LQ, Burbano RR, de Arruda Cardoso Smith M, Clin Exp Med 2009 9 319 325 10.1007/s10238-009-0051-3 19408098
28. Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease. Dixit M, Choudhuri G, Saxena R, Mittal B, Can J Gastroenterol 2007 21 569 575 17853951 (Pubitemid 350011440)
29. APOA1 polymorphism influences risk for early-onset nonfamiliar AD. Vollbach H, Heun R, Morris CM, Edwardson JA, McKeith IG, Jessen F, Schulz A, Maier W, Kolsch H, Ann Neurol 2005 58 436 441 10.1002/ana.20593 16130094 (Pubitemid 41266630)
30. Relationships among apolipoprotein A1 gene polymorphisms, lipid levels and coronary atherosclerosis disease. Zou Y, Hu D, Yang X, Jia X, Wang L, Cui L, Liu X, Gao M, Wei Y, Xu Z, Chin Med J (Engl) 2003 116 665 668 12875674 (Pubitemid 36701841)